Journals / Cukurova Medical Journal / 2022 / Cilt: 47 - Sayı: 2

Mediating effect of disease severity on the relationship between smoking status and quality of life in psoriasis patients

Psoriasis hastalarında sigara içme durumu ile yaşam kalitesi arasındaki ilişkide hastalık şiddetinin aracı etkisi

Pages
792–799
Publication Date
2022-10-12
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: In the study, it was found that smoking negatively affects the quality of life through both disease severity.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Purpose: The aim of this study was to examine the relationship between smoking and quality of life and to investigate the mediating role of disease severity on this relationship in psoriasis patients.
📊
Key Findings & Data:Materials and Methods: In the study, 268 psoriasis patients were reached by the convenience sampling method.
💡
Conclusion & Impact:Conclusion: In the study, it was found that smoking negatively affects the quality of life through both disease severity.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Purpose: The aim of this study was to examine the relationship between smoking and quality of life and to investigate the mediating role of disease severity on this relationship in psoriasis patients. Materials and Methods: In the study, 268 psoriasis patients were reached by the convenience sampling method. In the study, patients' quality of life was measured with “dermatology quality of life index (DLQI)” and disease severity was measured with “psoriasis area and severity index (PASI)”. The effect of the independent variable (smoking) on the dependent variable (quality of life), both directly and indirectly through the mediating variable (disease severity), was examined by process analysis. Results: Smoking status shows statistically significant differences according to gender, age, marital status, occupation, and income groups. 17.02% of women and 44.09% of men smoke.19.74% of single and 33.85% of married smoke. 20% of unemployed and 39.13% of employees smoke. 17.76% of low-income, 50.91% of middle-income, and 40.98% of high-income people smoke. This cross-sectional study revealed that smoking in psoriasis has no direct effect on the quality of life, but that smoking has a full indirect effect on the quality of life through disease severity. Conclusion: In the study, it was found that smoking negatively affects the quality of life through both disease severity. Accordingly, it is recommended that patients be informed about the effect of smoking on their diseases.

Özet

Amaç: Bu çalışmada, psoriasis hastalarında sigara kullanımı ile yaşam kalitesi arasındaki ilişkinin incelenmesi ve bu ilişkide hastalık şiddetinin aracı rolünün araştırılması amaçlanmıştır. Gereç ve Yöntem: Çalışmada 268 psoriasis hastasına kolayda örnekleme yöntemi ile ulaşılmıştır. Çalışmada hastaların yaşam kaliteleri “dermatoloji yaşam kalite indeksi (DLQI)” ve hastalık şiddetleri ise “psoriasis alan ve şiddet indeksi (PASI)” ile ölçülmüştür. Ayrıca bağımsız değişkenin (sigara içme) bağımlı değişken (yaşam kalitesi) üzerindeki etkisi, hem doğrudan etkisi hem de aracı değişken (hastalık şiddeti) aracılığıyla dolaylı etkisi süreç analizi ile incelenmiştir. Bulgular: Sigara kullanma durumu cinsiyete, yaşa, medeni durumuna, mesleğe ve gelir gruplarına göre istatistiksel olarak anlamlı farklılık göstermektedir. Kadınların %17,02'si ve erkeklerin %44,09'u sigara içmektedir. Bekârların %19.74'ü ve evlilerin %33.85'i sigara içmektedir. İşsizlerin %20'si ve çalışanların %39,13'ü sigara içmektedir. Düşük gelirlilerin %17,76'sı, orta gelirlilerin %50,91'i ve yüksek gelirlilerin %40,98'i sigara içmektedir. Çalışmada temel olarak psoriasis hastalığında sigara içmenin yaşam kalitesi üzerinde doğrudan bir etkisinin olmadığı, ancak sigara içmenin hastalık şiddeti aracılığıyla yaşam kalitesi üzerinde dolaylı tam bir etkisinin olduğunu bulunmuştur. Sonuç: Çalışmada sigara içmenin hem hastalık şiddeti aracılığıyla yaşam kalitesini olumsuz etkilediği bulunmuştur. Buna göre hastalar sigara içmenin hastalıkları üzerindeki etkisi konusunda bilgilendirilmesi önerilmektedir.

🔖

Cite This Article

TOSUN, M., İLGÜN, G., TOSUN, N. (2022). Mediating effect of disease severity on the relationship between smoking status and quality of life in psoriasis patients. Cukurova Medical Journal, Cilt: 47 - Sayı: 2, 792–799. https://ajindex.com/articles/476685

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (18)

  1. WHO. Global Report on Psoriasis. Geneva, World Health Organization, 2016
  2. Griffiths CE, Armstrong AW, Gudjonsson JE, Barker JN. Psoriasis. Lancet. 2021; 397:1301-1315
  3. Seldin MF. The genetics of human autoimmune disease: a perspective on progress in the field and future directions. J Autoimmun. 2015;64:1-12
  4. Dika E, Bardazzi F, Balestri R, Maibach HI. Environmental factors and psoriasis. Curr Probl Dermatol. 2007;35:118-135
  5. Lee EB, Wu KK, Lee MP, Bhutani T, Wu JJ. Psoriasis risk factors and triggers. Cutis. 2018;102:18-20
  6. Zeng J, Luo S, Huang Y, Lu Q. Critical role of environmental factors in the pathogenesis of psoriasis. J Dermatol. 2017;44:863-872
  7. Barrea L, Nappi F, Di Somma C, et al. Environmental risk factors in psoriasis: the point of view of the nutritionist. Int J Environ Res Public Health. 2016;13:743
  8. Raychaudhuri SP, Gross J. Psoriasis risk factors: role of lifestyle practices. Cutis. 2000; 66:348-352
  9. Jankovic S, Raznatovic M, Marinkovic J, Jankovic J, Maksimovic N. Risk factors for psoriasis: a case– control study. J Dermatol. 2009;36:328-334
  10. Heller MM, Lee ES, Koo JY. Stress as an influencing factor in psoriasis. Skin Therapy Lett. 2011;16:1-4
  11. Jankowiak B, Kowalewska B, Krajewska-Kułak E, Khvorik DF. Stigmatization and quality of life in patients with psoriasis. Dermatol Ther. 2020;10:285- 296
  12. Roszkiewicz M, Dopytalska K, Szymanska E, Jakimiuk A, Walecka I. Environmental risk factors and epigenetic alternations in psoriasis. Ann Agric Environ Med. 2020;27:335-342
  13. Amoruso GF, Nisticò SP, Iannone L, Russo E, Rago G, Patruno C et al. Ixekizumab may improve renal function in psoriasis. Healthcare. 2021;9:543-548
  14. Constantin MM, Bucur S, Mutu CC, Poenaru E, Olteanu R, Ionescu RA et al. The ımpact of smoking on psoriasis patients with biological therapies in a Bucharest Hospital. J Pers Med. 2021;11:752-762
  15. Fortes C, Mastroeni S, Leffondré K, Sampogna F, Melchi F, Mazzotti E et al. Relationship between smoking and the clinical severity of psoriasis. AMA Arch Derm. 2005;141:1580-1584
  16. Attwa E, Swelam E. Relationship between smoking‐ induced oxidative stress and the clinical severity of psoriasis. J Eur Acad Dermatol Venereol. 2011;25:782-787
  17. Emre S, Metin A, Demirseren DD, Kilic S, Isikoglu S, Erel O. The relationship between oxidative stress, smoking and the clinical severity of psoriasis. J Eur Acad Dermatol Venereol. 2013;27:370-375
  18. Hayran Y, Yalçın B. Smoking habits amongst